Great Neck, NY, United States of America

John D Haley


 

Average Co-Inventor Count = 2.0

ph-index = 5

Forward Citations = 68(Granted Patents)


Location History:

  • Great Neck, NY (US) (1993 - 1999)
  • Sea Cliff, NY (US) (2007 - 2013)
  • Farmingdale, NY (US) (2011 - 2016)

Company Filing History:


Years Active: 1993-2016

Loading Chart...
Loading Chart...
15 patents (USPTO):

Title: **Innovator John D. Haley: Advancing Cancer Treatment Through Patents**

Introduction

John D. Haley, based in Great Neck, NY, is a notable inventor in the field of cancer treatment. With a remarkable portfolio of 15 patents, his innovative contributions focus on developing methods to enhance the effectiveness of cancer therapies, particularly those involving epidermal growth factor receptor (EGFR) kinase inhibitors.

Latest Patents

Among his latest patents, Haley has introduced groundbreaking inventions that provide diagnostic and prognostic methods predicting the effectiveness of EGFR kinase inhibitors in cancer patients. His first invention identifies biomarkers that signal the sensitivity of tumor cells to these inhibitors by assessing whether the tumor has undergone an epithelial to mesenchymal transition (EMT). Tumor cells that have undergone EMT exhibit reduced sensitivity to treatment, which underlines the importance of his methodology. Additionally, he has developed improved strategies for treating cancer patients that incorporate these identifying methods.

Haley’s second patent details a combination cancer therapy methodology, which involves administering a therapeutically effective amount of an anti-cancer agent alongside an IGF1R inhibitor compound. This inventive approach aims to enhance treatment efficacy for various tumors and tumor metastases, showcasing his commitment to advancing cancer care.

Career Highlights

Throughout his career, John D. Haley has made significant contributions while working with prominent companies, including Osi Pharmaceuticals and Oncogene Science. His research and innovations have not only influenced the development of targeted cancer therapies but have also inspired a new wave of research in oncology.

Collaborations

Haley's journey in innovation has been enriched through collaborations with distinguished coworkers such as Kenneth K. Iwata and J. Gordon Foulkes. These partnerships have facilitated valuable exchanges of ideas and expertise, further solidifying his status as a leading inventor in the field of cancer treatment.

Conclusion

John D. Haley's work exemplifies the vital role of innovations in the medical field, particularly in oncology. His patents represent significant advancements in understanding cancer treatment modalities, offering hope for enhanced therapeutic strategies that can lead to improved patient outcomes. As he continues to innovate, Haley remains a key figure in the ongoing fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…